Kotmayer, L., Romero Moya, D., Marin-Bejar, O., Kozyra, E., Català, A., Bigas Salvans, A., . . . Giorgetti, A. (2022). GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.
Citación estilo ChicagoKotmayer, Lili, Damià Romero Moya, Oskar Marin-Bejar, Emilia Kozyra, Albert Català, Anna Bigas Salvans, Marcin W. Wlodarski, Csaba Bödör, y Alessandra Giorgetti. GATA2 Deficiency and MDS/AML: Experimental Strategies for Disease Modelling and Future Therapeutic Prospects. 2022.
Cita MLAKotmayer, Lili, et al. GATA2 Deficiency and MDS/AML: Experimental Strategies for Disease Modelling and Future Therapeutic Prospects. 2022.
Precaución: Estas citas no son 100% exactas.